Express Pharma

JANUARY 16, 2024

“It is a known adverse reaction of many drugs…When prescribing any medicine, doctors take patient history and other individual factors into account to reduce the risk of any adverse reaction,” the statement said.

Adverse Reactions 103

Adverse Reactions Documentation 103

PharmaTech

FEBRUARY 12, 2024

The agency’s safety committee stressed the risk of potential adverse reactions involved with taking Paxlovid (nirmatrelvir, ritonavir) in combination with certain immunosuppressants.

Adverse Reactions 52

Adverse Reactions 52

The Pharmacist

APRIL 26, 2023

The Medicines and Healthcare products Regulatory Agency (MHRA) has issued a reminder to healthcare professionals about possible adverse reactions to nitrofurantoin.

Adverse Reactions 90

Adverse Reactions 90

Pharmacy Times

JUNE 20, 2023

A counterfeit medication was reportedly purchased at a retail pharmacy, appearing to have contained another type of diabetes medication that led to an adverse reaction.

Adverse Reactions 62

Adverse Reactions Diabetes 62

PharmExec

JUNE 2, 2023

New program seeks to reduce misuse and adverse reactions by simplifying prescription labels.

Adverse Reactions 52

Adverse Reactions Labelling 52

ALiEM - Pharm Pearls

MARCH 5, 2024

However, most adverse reactions from willow bark supplements have been associated with people who have aspirin allergies, with numerous cases of anaphylaxis [6]. Willow tree bark supplements are available as tablets, tinctures, powders, or tea. How does willow bark toxicity present?

Clinical Pharmacology 280

Clinical Pharmacology Adverse Reactions Compounding 280

NY Times

SEPTEMBER 8, 2020

The company halted late-stage trials of its coronavirus vaccine because of a serious suspected adverse reaction in a participant.

Adverse Reactions 98

Adverse Reactions Vaccines 98

Med Ed 101

AUGUST 30, 2023

In this polypharmacy case study, we review a medication list and try to identify areas to reduce medications and avoid adverse reactions. EK is a 66-year-old female with a past medical history of insomnia, diabetes, GERD, hypertension, hyperlipidemia, obesity, recurrent UTI, and osteoarthritis.

Diabetes 52

Diabetes Adverse Reactions 52

Pharmacy Times

AUGUST 11, 2023

Advancements in the development of amyloid-targeting monoclonal antibodies show promise for treating Alzheimer disease, but there have been concerns around cost, adverse reactions, and inequity of care for marginalized patients.

Adverse Reactions 48

Adverse Reactions 48

STAT

SEPTEMBER 7, 2022

 Moving forward, the company will expand patient monitoring in the trial to watch for low magnesium levels, which had resulted in a serious adverse reaction in one study participant that led the FDA to suspend testing earlier this year. Food and Drug Administration on changes to the study’s plan , BioPharma Dive writes. Moving

Adverse Reactions 130

Adverse Reactions Vaccines 130

Pharmaceutical Technology

MAY 19, 2023

Blurred vision and eye redness are the most common adverse reactions observed with Miebo. The two 57-day, double-masked, multi-centre, saline-controlled, randomised trials were conducted in 1,217 people with DED history and clinical signs of Meibomian gland dysfunction, a major cause of development and disease progression.

Adverse Reactions 133

Adverse Reactions 133

PharmExec

OCTOBER 3, 2022

New methods for signal detection offer the potential to identify adverse reactions from vaccines and drugs earlier. November 29th 2022 9 am CT |10 am ET | 3 pm BST | 4 pm CET Statistical signal detection is a crucial tool for rapidly identifying potential risks associated with pharmaceutical products.

Adverse Reactions 52

Adverse Reactions Vaccines 52

Pharmacy Times

JANUARY 4, 2023

Children who experienced COVID-19-induced multisystem inflammatory syndrome did not experience severe adverse reactions following COVID-19 vaccination.

Adverse Reactions 49

Adverse Reactions Vaccines 49

Express Pharma

NOVEMBER 26, 2023

Serious adverse reactions: Regarding serious adverse reactions (SARs), an interesting finding was made. On day 28, the higher-dose group’s risk of death was 8.3 per cent lower for patients in Europe, whereas there was essentially no difference (0.1 per cent) in India. While a larger percentage (-1.0 per cent).

Adverse Reactions 94

Adverse Reactions Diabetes Hospitals 94

LifeProNow

MARCH 10, 2023

The most common adverse reactions reported in at least 2% of patients treated with ZAVZPRET and at a frequency greater than placebo were taste disorders (includes dysgeusia and ageusia), nausea, nasal discomfort and vomiting. If a hypersensitivity reaction occurs, discontinue ZAVZPRET and initiate appropriate therapy.

Adverse Reactions 100

Adverse Reactions 100

European Pharmaceutical Review

OCTOBER 18, 2023

However, in the trials, the only observed adverse reaction for the treatment was diarrhoea. Overall, the data showed that XPHOZAH significantly reduced elevated serum phosphorus in patients receiving maintenance hemodialysis.

Adverse Reactions 110

Adverse Reactions Labelling 110

RX Note

APRIL 9, 2023

Interesting Features Extensive search options Global drug name search Drug search by indications (include off-label use), adverse drug reactions and contraindications. Drug Class Overviews Provides information on therapeutic use, comparative efficacy, adverse reactions and drug interactions.

Clinical Pharmacology 52

Clinical Pharmacology Adverse Reactions Labelling 52

illuminate.health

JULY 15, 2022

In this episode of A Virtual View, Cameron Hilt, MPH, talks to our CEO, Varun Goyal, about how better medication management via tele-pharmacy decreases adverse reactions to medications, the future of tele-pharmacy, and the applications of Artificial Intelligence in the field.

Adverse Reactions 52

Adverse Reactions 52

European Pharmaceutical Review

JANUARY 8, 2024

Healthcare professionals are asked to report any suspected adverse reactions. . ▼ This medicinal product is subject to additional monitoring. This will allow quick identification of new safety information. The post Innovative biologic for myasthenia gravis granted European approval appeared first on European Pharmaceutical Review.

Adverse Reactions 95

Adverse Reactions 95

Pharmaceutical Technology

MAY 23, 2023

Dizziness, flushing, eye oedema and peripheral oedema are the most common adverse reactions for Ayvakit. Ayvakit showed improvements in disease symptoms and measures of mast cell burden compared to placebo. The company is now offering Ayvakit at a recommended 25mg once-a-day dose for adults with ISM.

Adverse Reactions 98

Adverse Reactions Labelling 98

RX Note

JULY 30, 2023

Overdose (including prescribing or administration errors) Therapeutic failure Drug interactions Drug withdrawal NOTE: All adverse reactions are adverse drug event, but that not all adverse drug events will be adverse drug reactions. Does the reaction improve when a specific treatment is given?

Adverse Reactions 52

Adverse Reactions Patient Counseling Medical Records Documentation 52

Pharmaceutical Technology

JANUARY 13, 2023

Diarrhoea, decreased appetite, constipation, fatigue, musculoskeletal pain, neutropenia, vomiting, anaemia, leukopenia, thrombocytopenia, increased transaminases, nausea, and alopecia are the most common adverse reactions observed in the trial.

Adverse Reactions 128

Adverse Reactions Chemotherapy 128

Express Pharma

NOVEMBER 21, 2023

Due to its unique molecular structure, Ryzneuta may possess stronger GCSF receptor activation properties and avoid the potential problem (such as allergic reactions) caused by PEG or Tween-80. Ryzneuta is a novel dimeric G-CSF long-acting fusion protein without PEGylation or Tween-80.

Chemotherapy 95

Chemotherapy Adverse Reactions Immunity Immunization 95

Express Pharma

DECEMBER 13, 2023

The Korean Ministry of Food and Drug Safety (MFDS) has recently mandated the reporting of any suspected adverse reactions, including T-cell malignancies, to the Korea Institute of Drug Safety and Risk Management.

Adverse Reactions 98

Adverse Reactions 98

Pharmaceutical Technology

MARCH 1, 2023

Rash pruritic, leukopenia, myalgia, injection site pruritus, neutropenia, fatigue, and constipation were the typical adverse reactions observed in the patients treated with Kevzara. The trial met its primary endpoint, with 28% of patients treated with Kevzara achieving sustained remission compared to 10% for placebo at 52 weeks.

Adverse Reactions 98

Adverse Reactions 98

Pharmaceutical Technology

FEBRUARY 20, 2023

Vitreous floaters, ocular discomfort, conjunctival hemorrhage, and neovascular AMD were the most common adverse reactions observed in patients receiving Syfovre. Syfovre’s safety profile is well-demonstrated after approximately 12,000 injections over 24 months.

Adverse Reactions 98

Adverse Reactions Immunity Immunization 98

European Pharmaceutical Review

NOVEMBER 13, 2023

In these clinical trials, the most common adverse reactions were diarrhoea, thrombocytopaenia, nausea, headache, dizziness, fatigue, asthenia, abdominal pain and cough. This trial aimed to evaluate the efficacy and safety of momelotinib versus ruxolitinib for myelofibrosis in those who had not received a prior JAK-inhibitor therapy.

Adverse Reactions 88

Adverse Reactions Pharmaceutical Companies Pharmaceutical Companies 88

European Pharmaceutical Review

JULY 20, 2022

1 But while data on adverse reactions is rightly used to help with these decisions, there is currently no additional modelling on the positive impact regulatory action could have on public health. Withdrawing drugs over safety concerns requires careful analysis of the health benefits and risks by regulators. Study focus.

Adverse Reactions 81

Adverse Reactions Diabetes Hospitals Vaccines 81

pharmaphorum

DECEMBER 9, 2020

The most common adverse reactions seen in a trial cohort of 38,000 patients were at injection sites (84.1%) followed by fatigue (62.9%) and headache (55.1%), and serious adverse reactions occurred in 0% to 4.6% of participants.

Vaccines 110

Vaccines Adverse Reactions Documentation Immunity 110

Pharmacy Times

SEPTEMBER 22, 2022

Pharmacist education also helps prevent adverse reactions, maximizes outcomes for the symptomless disease.

Adverse Reactions 29

Adverse Reactions 29

Pharmaceutical Technology

DECEMBER 7, 2022

A reduced number of serious and severe adverse reactions (AR) were reported and balanced between the vaccine and placebo arms. . Effectiveness was backed by clinical efficacy showing that the vaccine offered an overall 79.5% clinical protective efficacy when the Delta variant of the virus was prevalent.

Vaccines 105

Vaccines Adverse Reactions 105

Pharmaceutical Technology

NOVEMBER 25, 2022

Nausea, fatigue, vomiting, reduced neutrophil count, alopecia and anaemia among others were observed to be the most prevalent adverse reactions. The safety profile of Enhertu in this trial was in line with those seen in prior studies without any new safety concerns reported.

Adverse Reactions 105

Adverse Reactions Chemotherapy Labelling 105

European Pharmaceutical Review

JUNE 29, 2023

However, the majority of participants did experience at least one serious adverse reaction related to the infusion procedure and the use of immunosuppressive medications needed to maintain the islet cell viability. Ten participants did not need insulin for more than five years.

Diabetes 95

Diabetes Adverse Reactions 95

RX Note

MARCH 20, 2023

Adverse Reactions (Significant): Considerations Useful for medication counselling. The same drug information content can be found at UpToDate , but with missing information in Storage/stability Preparation for Administration Extemporaneously Prepared Useful Features Extensive brand name search Covers international brand names too.

Adverse Reactions 52

Adverse Reactions 52

Pharmaceutical Business Review

MAY 1, 2023

Insomnia, upper respiratory tract infection, headache, application site pain, urinary tract infection, nausea, and diarrhea are the most common adverse reactions. This approval marks the first topical PDE4 inhibitor to receive approval outside of the US.

Adverse Reactions 52

Adverse Reactions Immunity Immunization 52

Pharmaceutical Business Review

JULY 4, 2023

Patients treated with LYTGOBI showed some most common adverse reactions including alopecia, constipation, diarrhoea, dry mouth, fatigue, hyperphosphatemia, and nail disorders. The study met the primary endpoint demonstrating an objective response rate of 42%, as assessed by independent review. months, a key secondary endpoint.

Adverse Reactions 52

Adverse Reactions Labelling 52

RX Note

MARCH 30, 2024

Classification Drug recalls can be classified to: 3 degrees based on the severity of quality defects and adverse reactions of the products Degree I: Products with major health risks that might cause serious injuries or death. Should be under an embargo within 24 hours. Degree II: Products with minor health risks or are substandard.

Adverse Reactions 40

Adverse Reactions Hospitals 40